World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 53 3922 3616 1796 1643 133 29706

Jianda Yuan publications per year

The chart shows the history of publications by Jianda Yuan between 2004 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jianda Yuan published across 23 years, from 2004 to 2026, averaging 10 papers a year. Output peaked at 87 publications in 2023. 5 of the 231 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 2004 to 2026. Vertical axis: number of publications, 0 to 87. Peak 87 publications in 2023. 2004: 2 publications 2005: 4 publications 2006: 3 publications 2007: 3 publications 2008: 3 publications 2009: 9 publications 2010: 15 publications 2011: 9 publications 2012: 11 publications 2013: 14 publications 2014: 13 publications 2015: 11 publications 2016: 15 publications 2017: 3 publications 2018: 1 publication 2019: 5 publications 2020: 3 publications 2021: 3 publications 2022: 4 publications 2023: 87 publications 2024: 8 publications 2025: 4 publications 2026: 1 publication
2004 2026

231 publications in total across all disciplines

View publications per year as a table
Jianda Yuan: publications per year, 2004 to 2026
Year Publications
2004 2
2005 4
2006 3
2007 3
2008 3
2009 9
2010 15
2011 9
2012 11
2013 14
2014 13
2015 11
2016 15
2017 3
2018 1
2019 5
2020 3
2021 3
2022 4
2023 87
2024 8
2025 4
2026 1
Total 231
Download as CSV

Jianda Yuan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jianda Yuan sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 132–141 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 133 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160 133
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Jianda Yuan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jianda Yuan sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177 53
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Jianda Yuan is affiliated with MSD in the United States and primarily works in the field of Medicine with a focus on Oncology. Their research spans several subfields including Epidemiology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, and Immunology.

The main topics of Yuan's work include:

  • Cancer Immunotherapy and Biomarkers
  • Nonmelanoma Skin Cancer Studies
  • Cutaneous Melanoma Detection and Management
  • CAR-T cell therapy research
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Treatments and Mutations
  • Immunotherapy and Immune Responses

Yuan has published extensively, with notable recent papers including:

  • "Hallmarks of Resistance to Immune-Checkpoint Inhibitors," 2022, Cancer Immunology Research
  • "Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial," 2022, Annals of Oncology
  • "Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition," 2021, European Journal of Cancer
  • "Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results," 2023, Nature Medicine
  • "Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors," 2020, Cancer treatment and research

Frequent publication venues for Yuan include:

  • Regular and Young Investigator Award Abstracts
  • arXiv (Cornell University)
  • Annals of Oncology
  • Journal of Clinical Oncology
  • Clinical Cancer Research

Yuan has collaborated with several coauthors on multiple occasions, with frequent collaborators being:

  • Burak Gümüşçü
  • Laurent Mortier
  • Åse Bratland
  • Mikhail Klochikhin
  • Michael Schenker

Best Publications

  • Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

    Naiyer A. Rizvi;Naiyer A. Rizvi;Matthew D. Hellmann;Matthew D. Hellmann;Alexandra Snyder;Alexandra Snyder;Pia Kvistborg

  • Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

    Alexandra Snyder;Vladimir Makarov;Taha Merghoub;Jianda Yuan

  • Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

    Héctor Peinado;Maša Alečković;Simon Lavotshkin;Irina Matei

  • Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

    Michael A. Postow;Margaret K. Callahan;Margaret K. Callahan;Christopher A. Barker;Christopher A. Barker;Yoshiya Yamada;Yoshiya Yamada

  • Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

    Vinod P Balachandran;Michael J Cavnar;Shan Zeng;Zubin M Bamboat

  • Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.

    Alexander Martens;Kilian Wistuba-Hamprecht;Marnix H Geukes Foppen;Jianda Yuan

  • Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.

    Bradley C. Carthon;Jedd D. Wolchok;Jianda Yuan;Ashish Kamat

  • Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting lymphocyte count after 2 doses correlates with survival

    Geoffrey Y. Ku;Jianda Yuan;David B. Page;Sebastian E. A. Schroeder

  • CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

    Jianda Yuan;Sacha Gnjatic;Hao Li;Sarah Powel

  • Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

    Jianda Yuan;Matthew Adamow;Brian A. Ginsberg;Teresa S. Rasalan

  • Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.

    Weijie Ma;Weijie Ma;Barbara M. Gilligan;Jianda Yuan;Jianda Yuan;Tianhong Li

  • Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

    David J. Chung;Marco Rossi;Emanuela Romano;Jennifer Ghith

  • Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma.

    Michael A. Postow;Michael A. Postow;Manuarii Manuel;Phillip Wong;Jianda Yuan

  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

    Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

  • A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.

    Heather L. McArthur;Adi Diab;David B. Page;Jianda Yuan

  • Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.

    Gundrun Ratzinger;Jan Baggers;Maria A. de Cos;Jianda Yuan

  • Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

    Sylvia Janetzki;Katherine S. Panageas;Leah Ben-Porat;Jean Boyer

  • Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy

    Derek Ng Tang;Yu Shen;Jingjing Sun;Sijin Wen

  • Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation

    Miguel-Angel Perales;Miguel-Angel Perales;Jenna D. Goldberg;Jenna D. Goldberg;Jianda Yuan;Guenther Koehne;Guenther Koehne

  • Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

    Daniel Hirschhorn-Cymerman;Sadna Budhu;Shigehisa Kitano;Cailian Liu

  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

    Peter G. Maslak;Tao Dao;Lee M. Krug;Suzanne Chanel

Frequent Co-Authors

Jedd D. Wolchok
Jedd D. Wolchok Cornell University
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center
Michael A. Postow
Michael A. Postow Memorial Sloan Kettering Cancer Center
Katherine S. Panageas
Katherine S. Panageas Memorial Sloan Kettering Cancer Center
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Paul B. Chapman
Paul B. Chapman Memorial Sloan Kettering Cancer Center
Alan N. Houghton
Alan N. Houghton Memorial Sloan Kettering Cancer Center
Sacha Gnjatic
Sacha Gnjatic Icahn School of Medicine at Mount Sinai
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Many students consider nursing pathways due to their strong connection to the immune system and patient care. If you are looking for accessible entry points, programs like which LPN programs are easiest to get into offer practical routes to start a nursing career.

Advancing beyond LPN, becoming a Nurse Practitioner is a popular choice. To find programs that simplify admission without compromising quality, explore nurse practitioner programs with easy admission. Such programs are designed to accommodate various student backgrounds and pacing.

Specializing within nursing, psychiatric mental health care offers rewarding work supporting mental health, often linked to immunological research. The best psychiatric mental health nurse practitioner programs online combine flexible learning with strong clinical placements, ensuring practical experience is prioritized.

Cost is also a significant factor when choosing a degree. For those prioritizing affordability, the cheapest psych NP programs provide budget-friendly options without sacrificing educational standards.

By considering these related online degrees and career pathways, students interested in Immunology can find tailored programs that fit their goals, budget, and learning preferences while building essential healthcare expertise.

Best Scientists Citing Jianda Yuan

Trending Scientists

Recently Published Articles